What is a stock summary page? Click here for an overview.
Teva Pharmaceutical Industries Ltd (NYSE:TEVA) Stock News, Headlines & Updates
Teva Pharmaceutical Industries Ltd Stock News from GuruFocus
- 1
- 2
May 09, 2025
Decoding Teva Pharmaceutical Industries Ltd (TEVA): A Strategic SWOT Insight
GuruFocus News • 11:06pm
May 08, 2025
Teva Pharmaceutical (TEVA) Sees Price Target Raised by B of A Securities | TEVA Stock News
GuruFocus News • 1:32pm
Teva Pharmaceutical Industries Ltd (TEVA) Stock Price Up 3.44% on May 8
GuruFocus News • 12:13pm
Teva Pharmaceutical Industries Ltd (TEVA) Q1 2025 Earnings Call Highlights: Strong Growth in Innovative Brands and Strategic Transformation
GuruFocus News • 1:06am
Q1 2025 Teva Pharmaceutical Industries Ltd Earnings Call Transcript
GuruFocus News • 11:09pm
May 07, 2025
Teva (TEVA) Stock Surges on Strong Earnings and Raised Guidance
GuruFocus News • 1:26pm
Teva Pharmaceutical (TEVA) Sustains Growth with Strong Q1 2025 Results
GuruFocus News • 10:55am
Teva Pharmaceutical (TEVA) Sees Revenue Miss Despite Growth in Key Segments
GuruFocus News • 9:00am
Teva Pharmaceutical (TEVA) Adjusts 2025 Revenue and Earnings Forecast
GuruFocus News • 7:03am
Teva Pharmaceutical Industries Ltd Surpasses EPS Estimates with $0.18, Reports $3.9 Billion Revenue in Q1 2025, Slightly Missing Revenue Projections
GuruFocus News • 6:31am
Teva Reports Ninth Consecutive Quarter of Growth in Q1 2025 With Key Innovative Medicines Growing ~40%; 2025 Profit Outlook Improved
Marketwired • 6:00am
Teva to Host Innovation & Strategy Day on Thursday, May 29 in New York City
Marketwired • 6:00am
May 06, 2025
Teva Pharmaceutical (TEVA) Earnings Outlook: Key Estimates Ahead of Q1 Results
GuruFocus News • 11:05am
May 05, 2025
Teva (TEVA) Gains FDA Nod for Biosimilar Selarsdi
GuruFocus News • 8:58am
Teva and Alvotech Announce FDA Approval of Interchangeability for SELARSDI™ (ustekinumab-aekn) with Stelara® (ustekinumab) | TEVA Stock News
GuruFocus News • 7:16am
Teva Pharmaceutical's SELARSDI Gains FDA Approval as Interchangeable with Stelara | TEVA stock news
GuruFocus News • 7:03am
Teva and Alvotech Announce FDA Approval of Interchangeability for SELARSDI™ (ustekinumab-aekn) with Stelara® (ustekinumab)
Marketwired • 7:00am
Apr 22, 2025
Teva Pharmaceutical Industries Ltd (TEVA) Shares Up 5.15% on Apr 22
GuruFocus News • 12:19pm
Apr 15, 2025
Teva Pharmaceutical Industries (TEVA) in Francisco Garcia Parames' Cobas Asset Management 1st-Half 2024 Commentary 2024 Q2
GuruFocus News • 4:04pm
Teva Pharmaceutical Industries (TEVA) in Francisco Garcia Parames' Cobas Asset Management 1st-Half 2024 Commentary 2024 Q2
GuruFocus News • 4:03pm
Apr 09, 2025
Teva Pharmaceutical Industries Ltd (TEVA) Trading Down 5.11% on Apr 9
GuruFocus News • 12:08pm
Apr 07, 2025
Teva Pharmaceutical's AJOVY Seeks FDA Approval for Pediatric Migraine Prevention
GuruFocus News • 8:10am
Teva Pharmaceutical Industries Ltd (TEVA) Launches Cost-Effective Biosimilar EPYSQLI in the U.S.
GuruFocus News • 8:10am
Teva (TEVA) Seeks FDA Approval for AJOVY Expansion in Pediatric Migraine Care
GuruFocus News • 7:58am
Teva (TEVA) Launches Epysqli, a Cost-effective Alternative to Soliris
GuruFocus News • 7:56am
Teva Announces FDA Filing Acceptance for AJOVY® (fremanezumab) in Pediatric Episodic Migraine Prevention
Marketwired • 7:00am
Teva and Samsung Bioepis Announce Biosimilar EPYSQLI® (eculizumab-aagh) Injection Now Available in the United States
Marketwired • 7:00am
Apr 02, 2025
U.S. Imposes Tariffs on Pharmaceutical Imports from India, China, and EU
GuruFocus News • 4:55pm
Mar 27, 2025
Teva Releases Q1 2025 Aide Memoire
Marketwired • 4:00pm
Teva to Host Conference Call to Discuss First Quarter 2025 Financial Results at 8 a.m. ET on May 7, 2025
Marketwired • 4:00pm
Mar 20, 2025
Teva Pharmaceutical Industries Ltd at Barclays Global Healthcare Conference Transcript
GuruFocus News • 11:52am
Teva Pharmaceutical Industries Ltd to Discuss New Data Presented for Duvakitug (Anti-TL1A) Phase 2b after ECCO Conference Call Transcript
GuruFocus News • 11:52am
Teva Pharmaceutical Industries Ltd at JPMorgan Healthcare Conference Transcript
GuruFocus News • 11:52am
Teva Pharmaceutical Industries Ltd to Discuss The Duvakitug (Anti-TL1A) Positive Phase 2b Results Call Transcript
GuruFocus News • 11:52am
Teva Pharmaceutical Industries Ltd at Bank of America Global Healthcare Conference Transcript
GuruFocus News • 11:52am
Teva Pharmaceutical Industries Ltd at Morgan Stanley Global Healthcare Conference Transcript
GuruFocus News • 11:52am
Teva Pharmaceutical Industries Ltd at Goldman Sachs Global Healthcare Conference Transcript
GuruFocus News • 11:52am
Teva Pharmaceutical Industries Ltd at Bank of America Healthcare Conference Transcript
GuruFocus News • 11:52am
Teva Pharmaceutical Industries Ltd Investor Day Transcript
GuruFocus News • 11:52am
Mar 10, 2025
Teva Pharmaceutical Industries Ltd (TEVA) Shares Gap Down to $14.615 on Mar 10
GuruFocus News • 12:01pm
- 1
- 2
Show
Entries
Headlines
Total 0- 1
No recent news